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Background: This study aimed to determine whether midlife obesity predicts heart failure (HF) over an extended
follow-up into old age.
Methods: We studied 7495 men (from a population sample of 9,998 men) without HF, who were 47–55 years old
when investigated in 1970 to 1973. All participants were followed up for 35 years, or until death, using the Swedish
National Inpatient Register (IPR) and the Cause of Death Register. Over follow-up, 1855 men (24.7%) were discharged
from hospital or died with a diagnosis of HF.
Results: There was a strong relation between obesity and future risk of HF, which was accentuated over the last years
of the long follow-up. After adjusting for age, the risk of HF increased stepwise with increasing body mass index (BMI),
even in those with a normal BMI (22.5–24.9) The subdistribution hazard ratio (SHR) was 1.20 (95% CI: 1.02–1.39) in men
with a normal BMI, 1.29 (95% CI: 1.11–1.50) for a BMI of 25–27.49, 1.50 (95% CI: 1.27–1.77) for a BMI of 27.5–29.99, and
1.62 (95% CI: 1.33–1.97) for a BMI >30. After adjusting for, age, smoking, occupational class, and physical activity,
the results were unchanged.
Conclusion: Obesity in midlife is strongly related to the long-term risk of developing HF extending into old age
where the risk is highest. Even normal body weight (BMI <25) was related to an increased risk of developing HF
during life. Because overweight and obesity are largely preventable, our findings further emphasize the importance of
public health interventions against the development of obesity.
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Overweight and obesity is an increasing problem world-
wide. Since 1980, obesity has doubled worldwide with an
even larger increase in some countries [1]. A number of
diseases, such as diabetes, cancer, dementia, and cardio-
vascular disease, including heart failure (HF) are related to
overweight and obesity [2,3]. The link between obesity
and HF is well established, and obesity is now recognised* Correspondence: lena.bjorck@gu.se
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unless otherwise stated.as a major risk factor for developing HF in the general
population, including elderly people [4-6].
HF is a common disease with an estimated prevalence
of approximately 2–2.5% in Sweden and other Western
countries and is more common in men than women
[7-11]. The prevalence of HF is strongly related to age,
increasing steeply from <1% in those aged 19 to 54 years,
to about 10% in age 85 and 20% in ages above 85 [11].
Even if the incidence of HF is decreasing [7,11,12],
which is the case in Sweden, an increasingly larger pro-
portion of elderly people in the population means that
HF will be a rising problem. Additionally, this increase
could be accentuated by an increasing proportion of
overweight and obese persons.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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well known, there is still a lack of information on to
which extent midlife obesity can predict HF in old age,
where the risk is highest. Further, the level of body weight
at which risk of HF starts to rise has not been determined.
Therefore, using data from a cohort of middle aged
men from a comparatively narrow age range who were
followed up for 35 years or until they died, we aimed to
investigate the association between different levels of
body weight and the cumulative risk of being hospitalized
with HF.
Methods
Data were derived from male participants from the inter-
vention group in the multifactor Primary Prevention
Study, which began in Gothenburg, Sweden, in 1970 [13].
All men in the city born between 1915–1925 (n = 30,000),
except those born in 1923 (because they were part of an-
other study), were randomized into three groups of 10,000
men each (one intervention group and two control
groups). The men in one of the groups (intervention
group; n = 9,998) were invited to a screening examination
to identify and treat risk factors. The intervention was es-
sentially a high-risk strategy directed towards men with
pronounced hypercholesterolaemia, severe hypertension,
or heavy smoking habits, according to pre-defined criteria,
with treatment offered at specialist clinics. The first
screening examination included 7,495 men (non-participa-
tion rate of 25% (2,503 men) in the intervention group
and took place between January 1970 and March 1973. All
men were free from known HF at the time of the first
screening. Limited subsamples of the control groups were
examined but apart from that no baseline data were col-
lected in these groups. During the first 12-year follow-up,
there were no significant differences in outcome with re-
spect to cardiovascular disease, cancer, or all-cause mor-
tality between the intervention group and the two control
groups [1,13]. Therefore, despite the fact that the men
took part in an intervention study, we consider the study
group to be representative of the general Gothenburg
male population. All participants gave their informed
consent to participate in the study. The study was ap-
proved by the Ethics Committee for Medical Research
at the University of Gothenburg.
Information on risk factors (smoking, physical activity
during leisure time, occupation, and diabetes) were ob-
tained by questionnaire. Screening examinations were
performed in the afternoon. Weight was measured in ki-
lograms to the nearest 0.10 kg and height was measured
in meters to the nearest 0.01 m. BMI was calculated as
weight in kilograms divided by the square of height in
meters. We used five categories of BMI: <22.5, 22.5-24.9,
25–27.49, 27.5-29.9, and ≥30 kg/m2, corresponding to
low normal, high normal, slightly overweight, overweightand obese. Blood pressure (BP) was measured to the
nearest 2 mm Hg in the sitting position after 5 min of
rest. Hypertension was defined as systolic blood pressure
(SBP) >140 mm Hg, diastolic blood pressure (DBP) >90 mm
Hg, or taking antihypertensive treatment. Total serum chol-
esterol levels were measured after fasting for ≥2 h and were
determined according to standard laboratory procedures.
Smoking habits and a previous history of ischemic heart dis-
ease (IHD) were obtained from the baseline questionnaire.
Smoking was defined using two categories: current smoker
or non-smoker (never or former smoker [>1 month]).
Physical activity during leisure time was categorized into
three levels: sedentary, moderate activity at least 4 hours
per week, and regular, strenuous activity for at least 2–3 h
per week. Occupation was used to classify men into five
occupational classes and was coded according to the
Swedish socio-economic classification system, the Socio-
Economic Index (SEI): (1) unskilled and semiskilled workers,
(2) skilled workers, (3) foremen in industrial production and
assistant non-manual employees, (4) intermediate non-
manual employees, and (5) employed and self-employed
professionals, higher civil servants, and executives. In this
study, we divided occupational status into three groups
using the SEI classification system: low (SEI codes 1, 2),
intermediate (SEI codes 3, 4), and high occupational status
(SEI code 5).Follow-up
All participants in the study were followed up from their
baseline examination until December 31, 2008, using the
personal identification number unique to all Swedish cit-
izens. A file with all participants was run against the
Swedish national Inpatient Register (IPR) and the Swedish
Cause of Death register. The IPR, established in 1964, has
operated on a nationwide basis since 1987, but all dis-
charges from Gothenburg hospitals have been entered in
the national register since 1970 (except for 1976 owing to
a legislative change for that single year) [14]. Loss due to
emigration was negligible. HF was defined as discharge
with a primary or secondary diagnosis of HF using the
Swedish International Classification of Disease (ICD) code
of 427.00 or 427.10 for ICD-8, 428A, 428B, or 428X for
ICD-9, or I50 for ICD-10.
For the purpose of identifying HF cases due to IHD, we
categorized all cases with a discharge diagnosis of non-fatal
acute myocardial infarction (AMI) and/or coronary revas-
cularization, either before or at any time after diagnosis of
HF due to IHD. Non-fatal myocardial infarction was de-
fined as a discharge code of 410 (ICD-8 and −9) or I21
(ICD-10). Coronary revascularization was defined as any
discharge with a discharge code of 410–414 (ICD-8 and −9)
or I20-I25 (ICD-10) and an operation code of any of 3066,
3080, 3067, 3127, 3091, 3029, FNA, FNC, or FNG.
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All statistical analyses were performed using SAS software
version 9.2 (SAS Institute Inc, Cary, North Carolina) and
R statistical system (version 2.15.1). Descriptive statistics
with baseline characteristics are presented for each BMI
class and risk factors. A major problem for long-term fol-
low up studies is the presence of competing events, such
as death. This could potentially end the follow-up for a
study subject in such a way that violates the random cen-
soring assumption when calculating risk differences in risk
factors. In the present study, a competing risk regression
was used to study the long-term risk of HF by risk factors
and BMI group. For this purpose, a modified Cox propor-
tional hazard regression analysis was used, yielding a sub-
distribution hazard ratio (SHR) with two sided 95%
confidence intervals (CIs) [2,3,15,16]. All estimates for the
risk of developing HF by BMI groups were adjusted for
age, IHD, smoking, physical activity, total serum choles-
terol levels, diabetes, hypertension, and occupational class
where each categorized risk level (based on the different
levels of the categorized risk factors) was compared
with the corresponding reference group. In addition, a
cumulative incidence curve was estimated. The R package
“cmprsk”, which is publicity available at the R archive net-
work site (http://cran.r-project.org/), was used to calculate
the SHR and cumulative incidence.
Results
Of the 7,495 men with no HF at time of the baseline
examination, 57 had prior self-reported IHD. The total
mean BMI was 25.5 (standard deviation [SD] ±3.1/kg/m2).Table 1 Baseline characteristics in 7,495 men by body mass in
Number of men* All BMI 22.5 B
(n = 7495) (n = 1180) (
Age, years, mean (SD) 51.1 (2.3) 51.0 (2.3) 5
S-cholesterol mmol/L, mean (SD) 6.46 (1.16) 6.19 (1.10) 6
SBP mm Hg, mean (SD) 149 (22) 143 (21) 1
Hypertension, % (n) 70. 1 (5245) 58.1 (685) 6
Diabetes, % (n) 2.0 (149) 2.7 (32) 1
IHD, % (n) 57 (0.76) 10 (0.85) 1
Current smoker 50.3 (3768) 65.1 (769) 5
Physical activity, % (n)
Regularly 15.8 (1166) 15.2 (176) 1
Moderate 58.3 (4308) 57.5 (664) 6
Inactive 26.0 (1920) 27.3 (315) 2
Occupational class
High 27.7 (2078) 26.8 (317) 2
Intermediate 44.2 (3314) 44.3 (524) 4
Low 28.1 (2102) 28.9 (341) 2
*If numbers do not add up to the total number it is due to missing data.
BMI indicates body mass index; SBP systolic blood pressure; and IHD ischemic hearThe overall mean age was 51.1 years, with no difference
between the BMI groups. As expected, serum cholesterol,
diabetes, SBP, and hypertension increased with rising BMI
(Table 1). Smoking was most common in those with a
BMI <22.5 (65.1%) and lowest in those with a BMI ≥30
(44.2%). BMI relative to occupational class showed an
inverted J-shaped curve with a higher incidence of over-
weight and obesity in individuals with intermediate occu-
pational class compared with those with high and low
occupational class (Table 1).
Study participants were followed for 189 934 person-
years during the 35-year follow-up, during which 1855
men (24.7%) were hospitalized with a diagnosis of HF.
Men with a BMI <22.5 had the lowest risk of HF and
were used as the reference group. After adjusting for
age, the risk of HF increased stepwise with increasing
BMI, with a discernible increase in risk even in men
with a normal BMI of 22.5–24.99 [SHR: 1.20, 95% CI:
1.02–1.39]. The SHR was 1.29 (95% CI: 1.11–1.50) in
men with a BMI of 25–27.49, 1.50 (95% CI: 1.27–1.77)
in those with a BMI of 27.5–29.99, and 1.62 (95% CI:
1.33–1.97) in those with a BMI >30 (Table 2). After
adjusting for age, IHD, smoking, occupational class, and
physical activity, the result were only slightly changed
(Table 2).
After further adjustment for total s-cholesterol, SBP,
hypertension, and diabetes, which are strongly associated
with body weight and may be regarded as mediators in
the causal chain, there was no significant increase in risk
in men with a BMI of 22.5–24.9 (SHR: 1.16; 95% CI:
0.99–1.36), while the risk was still increased amongdex (BMI) category
MI 22.5-24.9 BMI 25–27.49 BMI 27.5-29.9 BMI(≥30)
n = 2267) (n = 2222) (n = 1207) (n = 617)
1.1 (2.3) 51.2 (2.3) 51.2 (2.4) 51.1 (2.3)
.37 (1.15) 6.53 (1.15) 6.67 (1.13) 6.65 (1.22)
46 (21) 149 (22) 154 (22) 159 (22)
4.9 (1467) 71.9 (1595) 79.9 (963) 86.7 (535)
.5 (35) 1.7 (38) 2.0 (24) 3.2 (20)
0 (0.44) 18 (0.81) 13 (1.08) 6 (0.97)
2.9 (1199) 45.2 (1005) 44.2 (533) 42.5 (262)
7.0 (383) 17.9 (393) 12.0 (144) 11.7 (70)
0.1 (1360) 58.0 (1272) 58.1 (695) 52.8 (317)
2.5 (505) 24.1 (529) 29.9 (357) 35.6 (214)
9.9 (678) 28.7 (637) 24.7 (298) 24.0 (148)
4.0 (997) 45.2 (1005) 44.1 (532) 41.5 (256)
6.1 (591) 26.1 (580) 31.2 (377) 34.5 (213)
t disease.
Table 2 Lifetime risk of developing heart failure in 7,495 men by body mass index (BMI) with or without ischemic
heart disease













n = 7494 (95% CI) (95% CI) (95% CI)
All HF events (n = 1855)
BMI
<22.5 1182 234 29473 7.94 1.00 (ref) 1.00 (ref) 1.00 (ref)
22.5-24.99 2266 533 59057 9.03 1.20 (1.02-1.39) 1.19 (1.02-1.39) 1.16 (0.99-1.36)
25-27.49 2222 562 57564 9.76 1.29 (1.11-1.50) 1.30 (1.11-1.52) 1.26 (1.07-1.47)
27.5-29.9 1207 342 29864 11.45 1.50 (1.27-1.77) 1.51 (1.28-1.79) 1.44 (1.21-1.71)
≥30 617 184 13976 13.17 1.62 (1.33-1.97) 1.61 (1.32-1.96) 1.51 (1.23-1.85)
HF without IHD (n = 851)
BMI
<22.5 1182 117 29888 3.91 1.00 (ref) 1.00 (ref) 1.00 (ref)
22.5-24.99 2266 251 60084 4.18 1.11 (0.89-1.38) 1.08 (0.87-1.35) 1.11 (0.88-1.38)
25-27.49 2222 247 58580 4.22 1.11 (0.89-1.38) 1.10 (0.89-1.37) 1.14 (0.91-1.43)
27.5-29.9 1207 153 30603 5.00 1.28 (1.01-1.63) 1.28 (1.00-1.63) 1.38 (1.07-1.77)
≥30 617 83 14352 5.78 1.39 (1.05-1.84) 1.39 (1.04-1.85) 1.52 (1.13-2.04)
HF and IHD (n = 1004)
BMI
<22.5 1182 117 29785 3.93 1.00 (ref) 1.00 (ref) 1.00 (ref)
22.5-24.9 2266 282 59844 4.71 1.26 (1.02-1.57) 1.28 (1.02-1.58) 1.20 (0.97-1.50)
25-27.49 2222 315 58386 5.40 1.44 (1.17-1.79) 1.47 (1.18-1.83) 1.34 (1.07-1.67)
27.5-29.9 1207 189 30440 6.21 1.62 (1.29-2.04) 1.65 (1.30-2.08) 1.43 (1.12-1.81)
≥30 617 101 14354 7.04 1.72 (1.32-2.25) 1.69 (1.29-2.23) 1.41 (1.07-1.86)
aAdjusted for age, IHD, smoking, physical activity and occupational status.
bAdjusted for age, IHD, smoking, physical activity, occupational class, total serum cholesterol, diabetes, systolic blood pressure and hypertension.
cIHD defined as acute myocardial infarction or revascularization (coronary artery bypass grafting (CABG) or percutaneus coronary intervention (PCI)).
HF indicates heart failure; BMI, body mass index; SHR, subdistribution hazard ratio and IHD, ischemic heart disease.
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1.07–1.47]; BMI of 27.5–29.9: SHR, 1.44 [95% CI: 1.21–
1.71]; BMI ≥30: SHR, 1.51 [95% CI: 1.23-1.85]) (Table 2).
The study population was then divided into HF without
overt IHD (45.9% of all HF) and HF with IHD in relation
to the BMI group. IHD was defined as prior AMI or car-
diovascular intervention (percutaneous coronary interven-
tion or coronary artery bypass grafting) at any time prior
or post HF. However, there was no evident difference in
the relation between midlife BMI and risk of HF between
the groups with and without IHD (Table 2).
In addition, we calculated the cumulative incidence for
HF, adjusted for competing risk, and further showed an
increasing incidence of HF over life in relation to the
BMI group. The strong relation between overweight and
obesity in midlife and the future risk of HF was accentu-
ated over the last years of the long follow-up, with more
than half of the cases occurring during the last 10 yearsof the study (Figure 1). A marked increase in hospitalization
for HF was observed 15 to 20 years after the baseline
examination.
Even in men with a BMI <25 in midlife, which is con-
sidered as normal weight, the cumulative risk of HF was
between 19.1% and 22.4%, increasing progressively to
23.9% and 27.3% in men with a BMI ≥25 to <30 and to
29.1% in those with a BMI ≥30.
Discussion
In the present study, we found that weight in midlife
was strongly related to the future risk of HF, extending
into old age where the majority of cases occur. Even
weight considered as normal (BMI of 22.5–25), not only
overweight or obesity, was related to an increased risk of
developing HF. This finding suggests a low threshold
with respect to body weight and the risk of developing
HF. Adjustment for other risk factors did not substantially
Figure 1 Cumulative incidence and long-term risk of developing
heart failure by BMI group.
Björck et al. BMC Cardiovascular Disorders  (2015) 15:19 Page 5 of 6alter our results. However, since symptoms in HF and in
obesity partly are similar HF could be detected more often
in persons with higher BMI. It has earlier been shown that
the prevalence of subjective symptoms of HF in people
with obesity is higher or similar but that the prevalence of
objective signs is lower. Consequently patients with higher
BMI could have been diagnosed at an earlier phase of HF
than those with lower BMI which furthermore could have
influenced the prevalence of HF [17].
HF increases steeply with age and is common in old
age where the risk of mortality is high. The cumulative
risk method that we used assumes that people who die
during the long follow-up period would have the same
risk of developing the disease as those who survived.
Therefore, we adjusted for competing risk to avoid over-
estimation of the long-term risk of HF. Even with this
adjustment, final risk of HF after 35 years was substan-
tial, adding to the literature that shows that HF is highly
prevalent among elderly people [7,18]. A recent study,
including all Swedish men and women hospitalized be-
tween 1990 and 2007 with a discharge diagnosis of HF,
showed a prevalence of 9% at 75–84 years and a preva-
lence of 20% in those aged >85 years [11]. This is con-
sistent with our findings where half of the HF cases
occurred during the last 10 years of the follow-up when
the men were aged between 80 and 85 years old.
HF is a major cause of morbidity and mortality in the
population, not only at the community level, but also for
individuals. Our study indicated the size of the problem
and also suggested that HF will be a growing health
issue in the future with the aging of the population.
Moreover, with and an increasing prevalence of over-
weight and obesity in the population these results are
highly relevant [19]. In addition, the total cost for HF
patients, including hospital care, primary health care,
nursing homes, investigations, and medication is high,
and will increase further with an ageing population [20].Potential mechanisms for the link between overweight/
obesity include cardiac remodelling with left ventricular
hypertrophy and left atrial enlargement. These are associ-
ated with diastolic dysfunction and its progression to sys-
tolic dysfunction, probably related to neurohormonal
activation and oxidative stress [21-23] IHD is estimated to
cause approximately half of all HF cases [24], and because
obesity, especially abdominal obesity [25,26], is a risk
factor for myocardial infarction, part of the increase in
risk could be mediated by IHD. Nevertheless, we found
that BMI in midlife was related to the risk of developing
HF also in cases without IHD.Strengths and limitations
Our study showed that 24.7% of the men developed HF
during the 35-years follow-up which is line with a recent
Swedish study where the prevalence of HF in men aged
>80 was 21.6% in age 89–89 and 30.3% in ages >90 [7].
The strength of our study is that we had a large sample
size, with very long follow-up of over more than 3 de-
cades with negligible loss of follow-up and providing a
sufficient number of HF cases occurring in advanced
age. However, there are also some limitations to our
study. First, HF was defined as discharge with a primary
or secondary diagnosis using the Swedish IPR registers,
with data collected for administrative and not for re-
search purposes. Even so, a hospital diagnosis of HF in
Sweden in the relevant period has been shown to have
good validity [27]. Secondly, HF was not assessed at
base-line and men with prior HF could accordingly have
been included in the study. However, since HF is rare in
this age group this is unlikely to have had an effect [11].
Third, only those men who were hospitalized for HF
were included in the study. This could have led to an
underestimation of the incident cases in our study be-
cause milder cases of HF are handled in outpatient care
[7]. Regardless, hospitalizations are considered to bear
the brunt of cost and suffering in connection with HF.
In addition, the study was designed as an intervention
trial. However, no significant difference in outcome with
respect to ischemic heart disease, cancer, or all-cause
mortality was found between the intervention group and
the two control groups [16].
In addition, our study included only men, which is a
limitation because HF is common in men and women.
Accordingly the conclusions of the study are limited to
men. Also, we only had information on BMI at baseline
and at the re-examination four years after the baseline
examination and no information on body weight or
weight change later in life, which may also influence the
life risk of developing HF. Misclassification of any given
exposure may obviously influence results. However, our
results indicate that overweight and obesity in midlife,
Björck et al. BMC Cardiovascular Disorders  (2015) 15:19 Page 6 of 6without further information on subsequent weight devel-
opment, is a strong predictor for HF in advanced age.
Conclusions
In our sample of men, the long-term risk of being hospi-
talized with HF was considerable, and increased incre-
mentally with midlife body weight at all levels beyond a
BMI of 22.5 kg/m2. This was partly mediated by the ef-
fect of body weight on cholesterol, diabetes, SBP and
hypertension such that there was overall no independent
effect below a BMI of 25 kg/m2. Still, the study shows
that even moderately increased body weight in midlife,
not only obesity, can predict the risk of developing HF
later in life. Our findings further emphasize the import-
ance of public health measures in order to prevent the
development overweight and obesity in middle-aged
people.
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